TLR2 and Parkinson disease: Moreover, the accumulating body of evidence demonstrates that TLR2, acting as a receptor for pathological α-synuclein, can mediate neuroinflammation in PD and contribute to neurodegeneration, eventually resulting in disease progression [36, 62–64].